SCHEMBL28825372

SCHEMBL28825372

CCOc1cc(Cl)c(C#N)c(N2CCCC2)c1OCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.41
LMNA P02545 5/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
ALDH1A1 P00352 9/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
MAPT P10636 4/20 0.40
MAPK1 P28482 4/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
MPI P34949 2/20 0.40
MCL1 Q07820 2/20 0.40
GAA P10253 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
POLB P06746 2/20 0.39
RAB9A P51151 2/20 0.39
HPGD P15428 2/20 0.39
BLM P54132 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14754042 0.85 ALDH1A1 (0.38) KDM4ELMNACYP1A2CYP3A4CYP2C9
SCHEMBL14736017 0.84 ALDH1A1 (0.37) KDM4ELMNACYP1A2CYP3A4CYP2C9
SCHEMBL14742195 0.83 ALDH1A1 (0.36) KDM4ELMNACYP1A2CYP3A4CYP2C9
SCHEMBL14736130 0.83 ALDH1A1 (0.36) KDM4ELMNAALDH1A1MEN1KMT2A
SCHEMBL14736216 0.82 L3MBTL1 (0.42) KDM4ELMNACYP3A4ALDH1A1MEN1
SCHEMBL14742430 0.82 ALDH1A1 (0.36) KDM4ELMNACYP1A2CYP3A4CYP2C9
SCHEMBL28048048 0.75 KDM4E (0.43) KDM4ELMNACYP1A2CYP3A4CYP2C9
SCHEMBL14736088 0.68 PIK3CD (0.33)
SCHEMBL14736760 0.67 PIK3CD (0.36)
SCHEMBL14742221 0.67 EGLN2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106986867-B Heterocycle amine as PI3K inhibitor 因塞特控股公司 2019-06-28 CN disclosed
CN-109010343-A The purposes of Pyrazolopyrimidine derivative treatment PI3K δ associated disease 因赛特公司 2018-12-18 CN disclosed
CN-104024253-B Heterocyclic amines as PI3K inhibitors INCYTE HOLDINGS CORP. (US) 2016-11-30 CN disclosed
CN-105120871-A Use of pyrazolopyrimidine derivatives for the treatment of PI 3K-related disorders INCYTE CORP 2015-12-02 CN disclosed